The Make America Healthy Again (MAHA) Commission has dropped its roadmap, and while the headlines sound like the usual policy fare (“modernize vaccines,” “expand injury research,” “re-evaluate childhood schedules”), what’s really happening is a communications earthquake. Ignore it, and you do so at your own peril. The post Vaccines, DTC, MAHA, and the Battle for Trust: Why Pharma Can’t Afford to Sit This One Out appeared first on maslansky+partners.
